公开(公告)号：US20230173173A1

公开(公告)日：2023-06-08

申请号：US18160724

申请日：2023-01-27

Applicant: INSULET CORPORATION

Inventor： Jason O'CONNOR ,  Joon Bok LEE ,  Ian MCLAUGHLIN ,  John D'ARCO

IPC: A61M5/158 ,  A61B5/145 ,  A61B5/00 ,  A61M5/142 ,  A61M31/00

CPC classification number: A61M5/158 ,  A61B5/14532 ,  A61B5/4839 ,  A61M5/14244 ,  A61M31/002 ,  A61B2562/0219 ,  A61M2005/14208 ,  A61M2005/14252 ,  A61M2005/1585

Abstract: A drug delivery device may include an Inertial Measurement Unit (IMU) is provided. The IMU may include an accelerometer, a magnetometer, or a gyroscope. Motion parameters may be detected when the drug delivery device is shipped, being prepared for activation for use, or during use. The IMU may provide data indicative of a rapid deceleration, such as when a package containing the drug delivery device is dropped, or some other physical event experienced by the drug delivery device. The drug delivery device may also include internal or external pressure sensors or a blood glucose sensor that may coordinate with the IMU to provide additional feedback regarding the status of the device or user. A controller of the drug delivery device may generate a response depending on the particular parameters being monitored or may change device operational parameters as a result of detected system events.

公开(公告)号：US20230162833A1

公开(公告)日：2023-05-25

申请号：US18151582

申请日：2023-01-09

Applicant: INSULET CORPORATION

Inventor： David NAZZARO ,  Steven CARDINALI ,  Nicholas CONTE ,  Daniel ALLIS ,  Jason O'CONNOR ,  Joon Bok LEE ,  Ashutosh ZADE ,  Timothy HENNING ,  Thomas METZMAKER ,  Ian MCLAUGHLIN

IPC: G16H20/60 ,  G16H20/17

CPC classification number: G16H20/60 ,  G16H20/17

Abstract: Disclosed are examples of a device, a system, methods and computer-readable medium products operable to implement functionality to determine and respond to a purpose of a meal. An algorithm or application may receive data that may include data related to a meal purpose from data sources and determine whether any of the data received from the plurality of data sources was received from a direct data source or an indirect data source. The data may be evaluated to determine a purpose of the meal. Based on the results of the evaluation, instructions may be generated to provide an appropriate response based on the determined purpose of the meal. The generated instructions to provide the appropriate response based on the determined purpose of the meal may be output.

公开(公告)号：US20230120570A1

公开(公告)日：2023-04-20

申请号：US18047071

申请日：2022-10-17

Applicant: INSULET CORPORATION

Inventor： Maureen MCCAFFREY ,  Soroush KAMRAVA ,  Ian MCLAUGHLIN

IPC: A61M5/142

Abstract: Disclosed herein are structures for ensuring that the reservoir of drug delivery device is free from any residual air before the device is filled with a liquid drug and put into use. The structures described herein are designed to prevent air from entering the reservoir during the pendency of a shelf life of the drug delivery device and/or to remove any residual air that has entered the reservoir of the drug delivery device prior to it being filled with the liquid drug.

公开(公告)号：US20220331521A1

公开(公告)日：2022-10-20

申请号：US17855910

申请日：2022-07-01

Applicant: Insulet Corporation

Inventor： David NAZZARO ,  Ian MCLAUGHLIN ,  Maureen MCCAFFREY ,  Simon KOZIN ,  Jackie MAC

IPC: A61M5/20 ,  A61M5/142 ,  A61M5/315

Abstract: A wearable drug delivery device that can deliver a liquid drug stored in a container to a patient is provided. The container can be a prefilled cartridge that can be loaded into the drug delivery device by the patient or that can be preloaded within the drug delivery device when provided to the patient. A sealed end of the container is pierced to couple the stored liquid drug to a needle conduit that is coupled to a needle insertion component that provides access to the patient. A drive system of the drug delivery device can expel the liquid drug from the cartridge to the patient through the needle conduit. The drive system can be controlled to provide the liquid drug to the patient in a single dose or over multiple doses.

公开(公告)号：US20220096749A1

公开(公告)日：2022-03-31

申请号：US17487570

申请日：2021-09-28

Applicant: Insulet Corporation

Inventor： Steven CARDINALI ,  David NAZZARO ,  Ian MCLAUGHLIN

IPC: A61M5/172

Abstract: Embodiments of the present disclosure relate to approaches for more efficiently measuring glucose levels using a wearable drug delivery device. In some embodiments, the wearable drug delivery device may include a needle deployment component including a cannula and an optical conduit deployable into a user, the cannula operable to deliver a liquid drug to the user. The wearable drug delivery device may further include a glucose monitor including an optical sensor, the optical sensor operable to measure a light output received via the optical conduit.

公开(公告)号：US20200297920A1

公开(公告)日：2020-09-24

申请号：US16897988

申请日：2020-06-10

Applicant: Insulet Corporation

Inventor： Ian MCLAUGHLIN

IPC: A61M5/00 ,  A61L2/20 ,  A61M5/31 ,  A61L2/00

Abstract: A system for sterilizing a drug delivery device includes a drug delivery device having a first self-healing seal configured to seal a fluid reservoir disposed within the drug delivery device. A sealable container is configured to receive the drug delivery device therein. The sealable container has a base portion and a cover portion. The cover portion has a second self-healing seal positioned to align with the first self-healing seal when the drug delivery device is disposed within the sealable container. A fill port includes a fill path, the fill path being configured to pass through the first and second self-healing seals to fluidly couple the fill port to the reservoir of the drug delivery device. Other systems, methods, and devices of sterilization are also disclosed.

公开(公告)号：US20200023123A1

公开(公告)日：2020-01-23

申请号：US16515749

申请日：2019-07-18

Applicant: Insulet Corporation

Inventor： Jason O'CONNOR ,  Ian MCLAUGHLIN ,  Daniel ALLIS ,  David NAZZARO

IPC: A61M5/145 ,  A61M5/142 ,  A61M5/158 ,  A61M5/162 ,  A61M5/168

Abstract: Disclosed are examples for a system for drug delivery and components thereof. The system may include an on-body pump device and a secondary unit. The on-body pump device may include a reservoir and a fluid pathway. The reservoir may be configured to hold a liquid drug. The secondary unit may be removably coupled to the on-body pump device. The secondary unit may be configured to receive a prefilled cartridge containing a liquid drug, expel the liquid drug from the prefilled cartridge, and deliver the liquid drug to the reservoir of the on-body pump device via the fluid pathway. Examples of variations to the secondary unit are also disclosed.

公开(公告)号：US20190091404A1

公开(公告)日：2019-03-28

申请号：US16140186

申请日：2018-09-24

Applicant: Insulet Corporation

Inventor： David NAZZARO ,  Ian MCLAUGHLIN ,  Maureen MCCAFFREY ,  Simon KOZIN ,  Jackie Mac

IPC: A61M5/20 ,  A61M5/315

Abstract: A wearable drug delivery device that can deliver a liquid drug stored in a container to a patient is provided. The container can be a prefilled cartridge that can be loaded into the drug delivery device by the patient or that can be preloaded within the drug delivery device when provided to the patient. A sealed end of the container is pierced to couple the stored liquid drug to a needle conduit that is coupled to a needle insertion component that provides access to the patient. A drive system of the drug delivery device can expel the liquid drug from the cartridge to the patient through the needle conduit. The drive system can be controlled to provide the liquid drug to the patient in a single dose or over multiple doses.

公开(公告)号：US20190038790A1

公开(公告)日：2019-02-07

申请号：US16053231

申请日：2018-08-02

Applicant: Insulet Corporation

Inventor： Ian MCLAUGHLIN

IPC: A61L2/20 ,  A61M39/18 ,  A61M5/142 ,  A61M5/28 ,  A61L2/08 ,  A61L2/26 ,  B65B3/00 ,  B65B55/04

Abstract: A method for sterilizing a drug delivery device may comprise disposing a liquid drug container, a needle conduit and a cap in a sterilization enclosure so that a mouth portion of the liquid drug container is registered with, and spaced apart from, a circumferential lip of the cap; disposing a cover over the liquid drug container, the needle conduit, and the cap, sealing the sterilization enclosure; subjecting the interior of the sterilization enclosure to a sterilization process in which the liquid drug container, the needle conduit, and the cap are exposed to the sterilization fluid and are sterilized; and applying a downward force to the liquid drug container to move the mouth portion into engagement with the circumferential lip of the cap and to snap the cap onto the liquid drug container to seal the cap and needle conduit to the liquid drug container in an assembled configuration.

公开(公告)号：US20180043105A1

公开(公告)日：2018-02-15

申请号：US15676604

申请日：2017-08-14

Applicant: Insulet Corporation

Inventor： David NAZZARO ,  Ian MCLAUGHLIN ,  Daniel ALLIS ,  Simon KOZIN ,  Maureen MCCAFFREY

IPC: A61M5/315 ,  A61M5/142 ,  A61M5/20

Abstract: Systems and methods for monitoring an operational state and/or a fill status of a drug container of a drug delivery device are provided. The drug container can hold a liquid drug. A plunger can be positioned within the drug container. A drive system can advance the plunger to expel the liquid drug from the container. A monitoring system can detect a movement and/or a position of the plunger and/or any component coupled to the plunger. The detection can enable determination of an amount of liquid drug that has been expelled and/or an amount of liquid drug remaining in the drug container. Dosing rates, flow rates, and dosage completion can also be determined.